Navigation Links
DATATRAK CTO Elected as CDISC Advisory Board Chair-Elect
Date:2/5/2013

CLEVELAND, Feb. 5, 2013 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced Chris Wilke , DATATRAK's Chief Technology Officer, was elected as the CDISC Advisory Board's (CAB) Chair-Elect. 

(Logo:  http://photos.prnewswire.com/prnh/20130107/CL38347LOGO)

"We are very pleased to have Chris Wilke as a member of the CDISC Advisory Board's leadership team. His many years of industry experience will add immense value to this group and will further promote our vision to inform patient care and safety through higher quality medical research," said Dr. Rebecca Kush , President and CEO, CDISC.

"Standards are key to effective sharing of clinical research data and ultimately, improving patient health," stated Chris Wilke , DATATRAK's CTO.  "After serving as a member of the Advisory Board for two years, I am excited to take a more active role in furthering CDISC's mission to develop and support global, platform-independent data standards."

As a Charter Platinum Member of CDISC, DATATRAK has a long history of supporting CDISC and its mission to define and implement standards industry-wide.  The Company currently holds CDISC Registered Solution Provider (RSP) status in the following categories:


  • CDASH
  • Define.XML
  • LAB
  • Operational Data Model
  • Study Data Tabulation Model

About DATATRAK

DATATRAK is the leader of unified eClinical® technologies and related services for the clinical trials industry.  Using the DATATRAK ONE™ multi-product, cloud-based clinical research platform, DATATRAK's Clinical and Consulting Services™ group assists clients in conducting Phase I-IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements.  For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on November 14, 2012 announcing its results for the three-month period ending September 30, 2012. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE DATATRAK International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. DATATRAK November Industry Events
2. DATATRAK International, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
3. DATATRAK International, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
4. DATATRAK Announces Accreditation Program
5. DATATRAK Expands CDISC Registered Solutions Provider Standards
6. NTT DATA Licenses DATATRAK ONE™ for China
7. Catherine M. Burzik Elected as BD Director
8. Varian Equipment Selected to Equip New Cancer Center in Algeria and Enable More Advanced Radiotherapy Treatments for Patients
9. Cerulean Pharmas Lead Candidate Selected as a "Top 10 Oncology Project to Watch"
10. Acuo Technologies Selected in Department of Defense Award to Deliver Vendor Neutral Archive for U.S. Army and U.S. Navy Medical Commands
11. Greenphires ClinCard Technology Platform selected by top 5 pharmaceutical company for long-term global clinical trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)... Sept. 8, 2017 Dealmed Medical Supplies, ... of medical equipment, supplies, drugs, vaccines, and specialty medical ... into an agreement to acquire Vantage Medical Supplies, a ... Holtsville, New York . ... new and emerging medical practices, will operate under the ...
(Date:9/7/2017)... , Sept. 7, 2017  Eli Lilly ... announced actions to streamline operations to more efficiently ... improve its cost structure. Global workforce reductions, including ... are expected to impact approximately 3,500 positions. ... company expects annualized savings of approximately $500 million ...
(Date:9/7/2017)... Texas , Sept. 7, 2017 ... science focused on fulfilling the promise of precision ... further validate the benefits of its molecular profiling ... study utilized comprehensive genomic profiling plus (CGP+) with ... individual patient,s tumor on a molecular level, leading ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... “The Financial Favor of God; Second Edition”: a ... Second Edition” is the creation of published author, Brooks Rathell. , “We typically hear ... to you about the financial favor of God. Not only does it exist, but ...
(Date:9/19/2017)... , ... September 19, 2017 , ... Only a few ... honorees include Brevard’s own Ross A. Clevens, MD, FACS . The founder and ... Facial Plastic and Reconstructive Surgeon who trained at Yale, Harvard and the University of ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... for the President’s Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) Project ... Award. , The Innovation to Action Award, a USAID Catalyst Award, recognizes ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... addition of Canyon Ranch to its recently formed Corporate Roundtable, a ... sustainable healthcare system and a sustainable world. , Canyon Ranch is a unique ...
(Date:9/19/2017)... FORT LEE, N.J. (PRWEB) , ... September 19, 2017 , ... ... of the Subperiosteal Implant: Volume II ” (published by Xlibris on July of 2014). ... and reviews conventional and new methodological approaches that benefit people who have lost ...
Breaking Medicine News(10 mins):